Citi analyst Yigal Nochomovitz lowered the firm’s price target on Biomea Fusion to $55 from $60 and keeps a Buy rating on the shares. The analyst cites dilution from the recent $160M financing for the target drop.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BMEA:
- 3 Best Stocks to Buy Now, 4/7/2023, According to Top Analysts
- This Insider Bought Biomea Fusion (NASDAQ:BMEA) Stock Worth $12M
- Biomea Fusion 5M share Secondary priced at $30.00
- Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock
- Biomea Fusion price target raised to $47 from $25 at Oppenheimer